rs3211938

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 8P and 9B. PVS1BP6BA1

The NM_001001548.3(CD36):​c.975T>G​(p.Tyr325*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00458 in 1,612,872 control chromosomes in the GnomAD database, including 414 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.025 ( 194 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 220 hom. )

Consequence

CD36
NM_001001548.3 stop_gained

Scores

1
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2B:1O:1

Conservation

PhyloP100: 0.457

Publications

98 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 7-80671133-T-G is Benign according to our data. Variant chr7-80671133-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 13536.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0848 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD36NM_001001548.3 linkc.975T>G p.Tyr325* stop_gained Exon 10 of 15 ENST00000447544.7 NP_001001548.1 P16671-1A4D1B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD36ENST00000447544.7 linkc.975T>G p.Tyr325* stop_gained Exon 10 of 15 5 NM_001001548.3 ENSP00000415743.2 P16671-1

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3739
AN:
152178
Hom.:
194
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0874
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00537
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00957
GnomAD2 exomes
AF:
0.00617
AC:
1545
AN:
250362
AF XY:
0.00437
show subpopulations
Gnomad AFR exome
AF:
0.0885
Gnomad AMR exome
AF:
0.00266
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00164
GnomAD4 exome
AF:
0.00249
AC:
3639
AN:
1460576
Hom.:
220
Cov.:
29
AF XY:
0.00218
AC XY:
1585
AN XY:
726654
show subpopulations
African (AFR)
AF:
0.0946
AC:
3162
AN:
33418
American (AMR)
AF:
0.00309
AC:
138
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39586
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53044
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000216
AC:
24
AN:
1111372
Other (OTH)
AF:
0.00471
AC:
284
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
155
311
466
622
777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0246
AC:
3740
AN:
152296
Hom.:
194
Cov.:
33
AF XY:
0.0233
AC XY:
1734
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0872
AC:
3623
AN:
41550
American (AMR)
AF:
0.00536
AC:
82
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68024
Other (OTH)
AF:
0.00947
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
168
335
503
670
838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00882
Hom.:
199
Bravo
AF:
0.0270
ESP6500AA
AF:
0.0819
AC:
361
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00788
AC:
956
Asia WGS
AF:
0.00520
AC:
18
AN:
3476
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Platelet-type bleeding disorder 10 Pathogenic:1Uncertain:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Jun 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Sep 11, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
May 09, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Malaria, cerebral, susceptibility to Other:1
Jun 01, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Pathogenic
0.49
CADD
Pathogenic
36
DANN
Uncertain
1.0
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Uncertain
0.82
D
PhyloP100
0.46
Vest4
0.85
GERP RS
-0.82
Mutation Taster
=197/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3211938; hg19: chr7-80300449; API